Details
Stereochemistry | ACHIRAL |
Molecular Formula | CHO3.CO3.3Na |
Molecular Weight | 189.995 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].[Na+].[Na+].OC([O-])=O.[O-]C([O-])=O
InChI
InChIKey=WCTAGTRAWPDFQO-UHFFFAOYSA-K
InChI=1S/2CH2O3.3Na/c2*2-1(3)4;;;/h2*(H2,2,3,4);;;/q;;3*+1/p-3
Molecular Formula | CHO3 |
Molecular Weight | 61.0168 |
Charge | -1 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | Na |
Molecular Weight | 22.9898 |
Charge | 1 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Potash (Dihydroxyaluminum Sodium Carbonate), a component of
Kompensan-S Forte in Germany, is a basic inorganic salt that acts by neutralizing hydrochloric acid in gastric secretions. Kompensan-S Forte is slowly solubilized in the stomach and reacts with hydrochloric acid to form aluminum chloride and water. It also inhibits the action of pepsin by increasing the pH and via adsorption. Cytoprotective effects may occur through increases in bicarbonate ion (HCO3-) and prostaglandins.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL261 Sources: https://www.drugbank.ca/drugs/DB09460 |
|||
Target ID: CHEMBL205 Sources: https://www.drugbank.ca/drugs/DB09460 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Kompensan Approved UseGastrointestinal disorders: Dyspepsia, Duodenal Ulcer, Erosive Esophagitis, Gastric Ulcer, Gastroesophageal Reflux Disease, Zollinger-Ellison Syndrome, Hyperphosphatemia |
PubMed
Title | Date | PubMed |
---|---|---|
Exchange of sodium by magnesium in aluminum hydroxycarbonate gel. | 1984 Jul |
|
Automation of dihydroxyaluminum sodium carbonate analysis in antacid tablets by energy dispersive X-ray fluorescence. | 1990 May-Jun |
|
Effect of pepsin on the kinetics of HCl neutralization by dihydroxyaluminum sodium carbonate, hydrotalcite and dihydroxyaluminum aminoacetate. | 1991 |
Sample Use Guides
Usual Adult Dose for Dyspepsia: 500 to 600 mg orally 4 to 6 times a day as needed, between meals and at bedtime. Usual Adult Dose for Duodenal Ulcer: 500 to 1500 mg orally 4 to 6 times a day as needed, between meals and at bedtime. Usual Adult Dose for Erosive Esophagitis: 500 to 1500 mg orally 4 to 6 times a day as needed, between meals and at bedtime. Usual Adult Dose for Gastric Ulcer: 500 to 1500 mg orally 4 to 6 times a day as needed, between meals and at bedtime. Usual Adult Dose for Gastroesophageal Reflux Disease: 500 to 1500 mg orally 4 to 6 times a day as needed, between meals and at bedtime. Usual Adult Dose for Zollinger-Ellison Syndrome: 500 to 3600 mg orally 4 to 6 times a day as needed, between meals and at bedtime. Usual Adult Dose for Hyperphosphatemia: 500 to 1000 mg orally 4 times a day, with meals and at bedtime. The dosage should be titrated to the serum phosphate level.
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 19:14:31 UTC 2023
by
admin
on
Fri Dec 15 19:14:31 UTC 2023
|
Record UNII |
Y1X815621J
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
EPA PESTICIDE CODE |
73507
Created by
admin on Fri Dec 15 19:14:31 UTC 2023 , Edited by admin on Fri Dec 15 19:14:31 UTC 2023
|
||
|
CODEX ALIMENTARIUS (GSFA) |
INS-500(III)
Created by
admin on Fri Dec 15 19:14:31 UTC 2023 , Edited by admin on Fri Dec 15 19:14:31 UTC 2023
|
||
|
JECFA EVALUATION |
INS-500(III)
Created by
admin on Fri Dec 15 19:14:31 UTC 2023 , Edited by admin on Fri Dec 15 19:14:31 UTC 2023
|
||
|
CFR |
21 CFR 184.1792
Created by
admin on Fri Dec 15 19:14:31 UTC 2023 , Edited by admin on Fri Dec 15 19:14:31 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SODIUM SESQUICARBONATE
Created by
admin on Fri Dec 15 19:14:31 UTC 2023 , Edited by admin on Fri Dec 15 19:14:31 UTC 2023
|
PRIMARY | |||
|
C029065
Created by
admin on Fri Dec 15 19:14:31 UTC 2023 , Edited by admin on Fri Dec 15 19:14:31 UTC 2023
|
PRIMARY | |||
|
208-580-9
Created by
admin on Fri Dec 15 19:14:31 UTC 2023 , Edited by admin on Fri Dec 15 19:14:31 UTC 2023
|
PRIMARY | |||
|
10791
Created by
admin on Fri Dec 15 19:14:31 UTC 2023 , Edited by admin on Fri Dec 15 19:14:31 UTC 2023
|
PRIMARY | |||
|
1367411
Created by
admin on Fri Dec 15 19:14:31 UTC 2023 , Edited by admin on Fri Dec 15 19:14:31 UTC 2023
|
PRIMARY | RxNorm | ||
|
DTXSID6049646
Created by
admin on Fri Dec 15 19:14:31 UTC 2023 , Edited by admin on Fri Dec 15 19:14:31 UTC 2023
|
PRIMARY | |||
|
m10073
Created by
admin on Fri Dec 15 19:14:31 UTC 2023 , Edited by admin on Fri Dec 15 19:14:31 UTC 2023
|
PRIMARY | Merck Index | ||
|
533-96-0
Created by
admin on Fri Dec 15 19:14:31 UTC 2023 , Edited by admin on Fri Dec 15 19:14:31 UTC 2023
|
PRIMARY | |||
|
769
Created by
admin on Fri Dec 15 19:14:31 UTC 2023 , Edited by admin on Fri Dec 15 19:14:31 UTC 2023
|
PRIMARY | |||
|
Y1X815621J
Created by
admin on Fri Dec 15 19:14:31 UTC 2023 , Edited by admin on Fri Dec 15 19:14:31 UTC 2023
|
PRIMARY | |||
|
Y1X815621J
Created by
admin on Fri Dec 15 19:14:31 UTC 2023 , Edited by admin on Fri Dec 15 19:14:31 UTC 2023
|
PRIMARY |